A

Azadyne Ltd

3 employees

Azadyne is a new approach to the treatment of autoimmune diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Multiple Sclerosis
queuine
Health Care
tRNA
Rheumatoid Arthritis
Pharmaceutical research & development
autoimmune disease

Date founded

2016

Funding rounds raised

Total raised

$2M

from 3 investors over 3 rounds

A

Azadyne Ltd raised undisclosed on September 3, 2020

Investors: Renaissance Capital Partners

A

Azadyne Ltd raised $2M on March 27, 2019

Investors: NCL Technology Ventures

A

Azadyne Ltd raised undisclosed on February 18, 2019

Investors: Renaissance Capital Partners

FAQ